Improved Axillary Evaluation Following Neoadjuvant Therapy for Patients With Node-Positive Breast Cancer Using

Abigail S Caudle1, Wei T Yang1, Savitri Krishnamurthy1

  • 1All authors: The University of Texas MD Anderson Cancer Center, Houston, TX.

Summary

Clipping breast cancer nodes with metastasis before neoadjuvant therapy and using targeted axillary dissection (TAD) significantly reduces the false-negative rate (FNR) for nodal staging. This approach improves accuracy in evaluating residual disease after chemotherapy.

Related Concept Videos